Subscribe to RSS
The Relationship between Serum Ischemia-Modified Albumin Levels and Uterine Artery Doppler Parameters in Patients with Primary Dysmenorrhea
Objective Primary dysmenorrhea occurs due to abnormal levels of prostanoids, uterine contractions, and uterine blood flow. However, the reasons for pain in primary dysmenorrhea have not yet been clarified. We examined the blood flow alterations in patients with primary dysmenorrhea and determined the relationship between ischemia-modified albumin (IMA) levels, as an ischemia indicator, and primary dysmenorrhea.
Methods In the present study, 37 patients who had primary dysmenorrhea and were in their luteal and menstrual phase of their menstrual cycles were included. Thirty individuals who had similar demographic characteristics, who were between 18 and 30 years old and did not have gynecologic disease were included as control individuals. Their uterine artery Doppler indices and serum IMA levels were measured.
Results Menstrual phase plasma IMA levels were significantly higher than luteal phase IMA levels, both in the patient and in the control groups (p < 0.001). Although the menstrual phase IMA levels of patients were significantly higher than those of controls, luteal phase IMA levels were not significantly different between the two groups. Menstrual uterine artery pulsatility index (PI) and resistance index (RI) of primary dysmenorrhea patients were significantly different when compared with luteal uterine artery PI and RI levels. There was a positive correlation between menstrual phase IMA and uterine artery PI and RI in the primary dysmenorrhea.
Conclusion Ischemia plays an important role in the etiology of the pain, which is frequently observed in patients with primary dysmenorrhea. Ischemia-modified albumin levels are considered as an efficient marker to determine the severity of pain and to indicate ischemia in primary dysmenorrhea.
All of the authors contributed to the conception and design of the present study, to the data collection, or to the analysis and interpretation of data, as well as to the writing of the article or to the critical review of the intellectual content and final approval of the version to be published.
Received: 16 April 2020
Accepted: 29 June 2020
Article published online:
31 October 2020
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Thieme Revinter Publicações Ltda
Rio de Janeiro, Brazil
- 1 Tekin YB, Güvendağ Güven ES, Kirbas A, Üstüner I, Doğan OD, Balik G, Şahin FK. The role of hypoxia at primary dysmenorrhea, utilizing a novel hypoxia marker--SCUBE1. J Pediatr Adolesc Gynecol 2015; 28 (01) 63-65 DOI: 10.1016/j.jpag.2014.05.001.
- 2 Patel JC, Patel PB, Acharya H, Nakum K, Tripathi CB. Efficacy and safety of lornoxicam vs ibuprofen in primary dysmenorrhea: a randomized, double-blind, double dummy, active-controlled, cross over study. Eur J Obstet Gynecol Reprod Biol 2015; 188: 118-123 DOI: 10.1016/j.ejogrb.2015.03.005.
- 3 Guedes-Martins L, Gaio R, Saraiva J, Cerdeira S, Matos L, Silva E, Macedo F, Almeida H. Reference ranges for uterine artery pulsatility index during the menstrual cycle: a cross-sectional study. PLoS One 2015; 10 (03) e0119103 DOI: 10.1371/journal.pone.0119103.
- 4 Altunyurt S, Göl M, Altunyurt S, Sezer O, Demir N. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med 2005; 50 (04) 251-255
- 5 Yang L, Cao Z, Yu B, Chai C. An in vivo mouse model of primary dysmenorrhea. Exp Anim 2015; 64 (03) 295-303 DOI: 10.1538/expanim.14-0111.
- 6 Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006; 92 (01) 113-114 DOI: 10.1136/hrt.2004.049643.
- 7 Cengiz H, Dagdeviren H, Kanawati A, Çaypinar SS, Yesil A, Ekin M, Yasar L. Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss. J Matern Fetal Neonatal Med 2016; 29 (11) 1754-1757 DOI: 10.3109/14767058.2015.1061494.
- 8 Celik H, Gurates B, Parmaksiz C, Polat A, Hanay F, Kavak B. et al. Severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea. Arch Gynecol Obstet 2009; 280 (04) 589-592 DOI: 10.1007/s00404-009-0966-7.
- 9 Dmitrović R. Transvaginal color Doppler study of uterine blood flow in primary dysmenorrhea. Acta Obstet Gynecol Scand 2000; 79 (12) 1112-1116 DOI: 10.1034/j.1600-0412.2000.0790121112.x.
- 10 Dmitrovic R, Peter B, Cvitkovic-Kuzmic A, Strelec M, Kereshi T. Severity of symptoms in primary dysmenorrhea--a Doppler study. Eur J Obstet Gynecol Reprod Biol 2003; 107 (02) 191-194 DOI: 10.1016/s0301-2115(02)00372-x.
- 11 van Rijn BB, Franx A, Sikkema JM, van Rijn HJM, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008; 27 (02) 159-167 DOI: 10.1080/10641950701885147.
- 12 Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod 2007; 22 (07) 2029-2032 DOI: 10.1093/humrep/dem095.